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Abstract 
Background: Sulfur mustard (SM) is a chemical warfare agent that has been repeatedly used since World War I. SM 
has chronic and deleterious effects on different body organs such as lungs, skin and eyes.  
Objectives: To determine dental and oral health status of chemical victims of SM who were exposed to SM during 
the Iraqi-Iran war.
Material and Methods: In this case-control study, 100 male subjects exposed to SM were chosen as cases, and 100 
non-exposed volunteers were chosen as controls. These groups were selected randomly according to their referral 
number, and were matched regarding age. Collection of information was performed using Oral Health Assessment 
Form designed by the World Health Organization. Quantitative and qualitative data were compared between the 
groups using independent samples t-test and Chi-square test, respectively. 
Results: There was a significant difference between the case and control groups with respect to the frequencies 
of oral candidiasis, pharyngeal erythema and/or hyperplasia, hairy tongue and reflux disease, being higher in the 
former group. There was also a positive association between the frequency of candidiasis and the percentage of 
disability; pharyngeal erythema and/or hyperplasia and use of salmeterol spray; and between hairy tongue and 
antibiotic use in the case group.
Conclusions: Exposure to SM and the use of drugs for controlling long-term complications does not increase the 
risk of tooth decay, tooth loss, and intra and/or extra oral lesions in patients, but may be associated with increased 
incidence of oral candidiasis, pharyngeal erythema and/or hyperplasia, hairy tongue and reflux disease.
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Introduction
Sulfur mustard (SM) gas is a chemical warfare agent that 
has been used repeatedly since the First World War. This 
gas is produced easily, even by developing countries, and 
its military use has led to great casualties (1). SM was 
employed extensively by the Iraqi army against Iranian 
soldiers, and also Iranian and Iraqi civilians between 
1983 and 1988, resulting in over 100,000 chemical ca-
sualties (2). Currently, a considerable number (~45,000) 
of SM-intoxicated subjects with chronic cutaneous, ocu-
lar and respiratory symptoms are living in Iran. SM is 
a yellow oily liquid with a stench of mustard or garlic 
in room temperature, and evaporates rapidly in hot and 
dry environments. SM affects different body organs and 
tissues by alkylation of nucleic acids and proteins (3). 
Its effects are long-lasting but not fatal (3% mortality 
in the second World-War) (1). SM is a strong blistering 
agent; each 0.1 mL is 20,000 times the required dose to 
cause blisters. There may be no signs or symptoms in 
the first 12 to 24 hours following exposure. In poisoning 
cases, erythema is usually seen prior to blistering (1). 
In many cases with SM-induced respiratory lesions, pri-
mary nasal and respiratory tract mucosal burn bronchitis 
develops within 4-6 weeks. In severe cases of exposure, 
necrosis of respiratory epithelium or oral mucosa results 
in the development of pseudomembrane and bronchop-
neumonia (4). Systemic absorption results in nausea, 
vomiting, hypotension, bradycardia and leukopenia fo-
llowing primary leukocytosis. Death is a result of infec-
tion, though it is uncommon (4,5).
SM has two types of effects on body: short-term and 
long-term. Its long term effects are due to its effects on 
intracellular components particularly DNA and proteins 
resulting in several biochemical imbalances and clinical 
manifestations (1-4) that are may not be completely con-
trolled by available treatments, and necessitate new mo-
dalities (5-13). These effects cause mutagenic and carci-
nogenic changes in long-term and can affect the integrity 
of oral mucosa as well as the hematologic parameters 
(6-8). Hematologic complications might be the result of 
bone marrow suppression and subsequent decrease in the 
number of bone marrow precursor cells, causing aplastic 
anemia (9-11). SM can also promote tumorigenesis and 
increase the risk of pulmonary, bladder, pharyngeal, and 
gastric cancers (11-13), as well as leukemia and malig-
nant melanoma (1). Chronic effects of SM also inclu-
de persistent inflammation of the oral cavity, pharynx 
and larynx, inflammation and ulceration of the palate, 
nasopharynx, oropharynx and cancer of the larynx, with 
temporary aphonia (1). Moreover, oral mucosal lesions 
are likely to be seen in SM-intoxicated patients either as 
a result of long-term effects of SM on immunological 
parameters, or the use of drugs for treatment of exposure 
complications (10). The aim of the present study was 
to determine dental and oral health status of chemically 
injured subjects exposed to SM compared with those of 
healthy subjects.
Material and Methods 
This case-control study was performed on 200 sub-
jects who referred to the Dental Clinic of the Baqiya-
tallah Hospital, Tehran, Iran. Patients were selected for 
this study randomly according to their referral number. 
Classification of subjects as case or control was based 
on the exposure to SM, and 100 subjects were included 
in each group. Percentage of disability for each subject 
in the case group was obtained from medical docu-
ments certified by the Veteran’s Affair of Iran (Janbazan 
Foundation). The procedure of determining disability 
percentage in chemically-injured subjects is based on 
the presence and severity (classified as mild, modera-
te or severe) of chronic cutaneous symptoms, delayed 
keratitis, and bronchiolitis (according to the findings of 
high-resolution computed tomography). Data collection 
was performed through observation and interview using 
WHO Oral Health Assessment Form 1997 (14) plus 
added questions regarding the percentage of disability, 
smoking habit, presence of other chronic complications 
due to SM exposure, location of exposure, and educa-
tional status. WHO Oral Health Assessment Form was 
used in the present study due to lacking any validated 
and standardized questionnaire for the evaluation of oral 
and dental health status in Iran. All patients were exa-
mined by an expert dentist. Radiographic pictures and 
digital photos of suspected lesions were taken if needed. 
Mouth dryness was assessed using Spitting test. Plaque 
Index was used for evaluating patient`s oral hygiene. 
Examinations were performed on a dental unit using 
WHO-approved equipment and methods. In case of acu-
te, severe and life-threatening complications, the patient 
was referred to an appropriate care center. The frequen-
cies of dental and oral problems including buccal pe-
techia, pharyngeal erythema/hyperplasia, hairy tongue, 
herpes, candidiasis, aphthous ulcers, oral habits, reflux, 
mouth dryness, and oral irritation, malodor and bleeding 
were determined in both groups and compared. Subjects 
with oral complications were referred to the respective 
specialist physician for further assessment, differential 
diagnosis, and treatment. Possible association between 
oral lesions and drugs used in SM-exposed patients was 
also evaluated. 
The study protocol was reviewed and approved by the 
institutional Ethics Committee at the Baqiyatallah Uni-
versity of Medical Sciences, Tehran, Iran.
Data were analyzed using SPSS software, version16 (SPSS 
Inc., Chicago, IL, USA). Between-group comparisons were 
made using Chi-square test for categorical variables, and 
independent samples t-test for numerical variables.
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Results
All studied subjects were male. The mean age in the to-
tal study population was 44.97±4.45 years (age range: 
36-64 years). Mean age in case and control groups were 
44.58±4.5 years, and 45.38±4.38 years, respectively. The 
groups were comparable with respect to age. Out of the 
total study population, 100 patients had pulmonary com-
plications, 75 skin symptoms, 48 ocular complications, 
32 neurologic symptoms, and 12 had other symptoms. 
Mean percentage of disability was 45.75±15.51% in 
case group. In the case group, 10 subjects were smoker 
compared with 22 subjects in the control group, being 
significantly different between the groups (p<0.05). 
Thirty-nine patients in case group and 34 in control 
group did not have high school graduation, which was 
comparable between the groups (p>0.05). Seventy-three 
patients in case group and 71 in control group had den-
tal visits in the preceding year, which was not signifi-
cantly different between the groups (p>0.05). Overall, 
there was no significant difference between the case and 
control groups regarding oral hygiene status according 
to the WHO Oral Health Assessment Criteria (p>0.05) 
(Table 1). The frequencies of buccal petechia, pharyn-
geal erythema/hyperplasia, hairy tongue, candidiasis 
and reflux disease were considerably higher in the case 
vs. control group (p<0.05). However, case and control 
groups were comparable with respect to the frequencies 
of herpes infection, aphthous ulcers, mouth dryness, oral 
irritation, oral malodor, and oral bleeding (p>0.05). The 
percentage of disability was significantly higher in the 
subgroup of subjects with candidiasis compared with 
candidiasis-free subgroup (p<0.05). Prevalence of hairy 
tongue and pharyngeal erythema/hyperplasia were hig-
her in the subgroups of patients taking antibiotics and 
salmeterol, respectively (p<0.05).  The mean numbers 
of lost teeth (5.67±4.69 in case group and 5.29±3.94 in 
control group) and filled teeth (6.28±3.22 in case group 
and 5.76±4.28 in control group) were not significantly 
different between the groups (p>0.05) (Table 2). The 
prevalence of antibiotic and corticosteroid use in the 
case group was 27% and 58%, respectively.
Discussion
In order to fulfill the objective of the present study, oral 
hygiene status of patients exposed to SM was compa-
red with age-matched non-exposed individuals. All SM-
exposed patients had pulmonary symptoms which is 
indicative of the sensitivity of lungs to toxic effects of 
SM. In addition to respiratory problems, dermal, ocu-
lar and neurological complications were also observed. 
Patients exposed to SM smoked significantly less than 
the control group, which may itself be a consequence 
of numerous pulmonary problems causing inability of 
subjects to smoke. The association between cigarette 
smoking and several oral problems such as periodonti-
tis, hairy tongue, leukoplakia, has been shown in pre-
vious studies (15,16). Smoking may potentially serve as 
a confounding factor for the higher frequencies of some 
of the symptoms in the case group. However, it is not 
likely that the higher prevalence of symptoms such as 
candidiasis in the case group that was observed in the 
present study is related to smoking because the number 
of smokers was significantly fewer in case vs. control 
group. The exact etiology for the higher rate of buccal 
petechia and pharyngeal erythema and/or hyperplasia 
in the SM-exposed group remains to be investigated by 
future studies. It is known that SM can cause hemato-
logical disturbances in both acute and chronic phases. 
In a large cohort among SM-exposed civilians of Iran, 
a significantly reduced platelet count was reported 20 
years after exposure, however that thrombocytopenia is 
a constant chronic feature of SM exposure has not been 
a consistent finding (17,18). Hairy tongue lesions were 
more prevalent in SM exposed patients; most probably 
as a result of higher antibiotic use in these patients. The 
association between extensive use of antibiotics and 
hairy tongue lesions has been previously demonstrated 
(9). Higher prevalence of candidiasis in the case group is 
Table 1. Distribution of patients based on oral hygiene principles.
SM: sulfur mustard. The proportion of subjects in each hygienic category did 
not significantly differ between SM and control groups (p>0.05).
 
 
Oral hygiene principles
Very poor Poor Fair Good Sum
SM group 13 30 50 7 100
Control 
group 9 28 56 7 100
Sum 22 58 106 14 200
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Sign 
SM Control group
p-value 
Yes No Yes No 
Smoking 10 90 22 78 <0.05
Buccal petechia 10 90 1 99 <0.05
pharyngeal erythema/ 
hyperplasia 53 47 13 87 <0.05
Hairy tongue 26 74 2 98 <0.05
HSV 3 97 1 99 >0.05
Candidiasis 10 90 2 98 <0.05
Aphthous ulcers 8 92 4 96 >0.05
Oral habits 6 94 7 93 >0.05
Reflux 60 40 23 77 <0.05
Mouth dryness 9 91 6 94 >0.05
Oral irritation 7 93 5 95 >0.05
Oral Malodor 5 95 7 93 >0.05
Oral bleeding 1 99 1 99 >0.05
Table 2. Frequency of oral abnormalities in the study groups.
SM: sulfur mustard.
probably due to immune suppression and simultaneous 
use of antibiotics and corticosteroids. There was only 
one case of squamous cell carcinoma located in the pos-
terior part of the tongue in the case group, with known 
etiology (constant stimulus with a broken tooth), and had 
no relation to SM exposure or consumed drugs. Prescri-
bed drugs in the case group were salbutamol, salmete-
rol, ipratropium bromide, fluticasone, beclomethasone 
and other corticosteroids, antibiotics, psychiatric drugs, 
methylxhantines and omeprazole. The rate of adheren-
ce to oral hygiene principles was comparable between 
the groups. This finding may be due to the proper dental 
care facilities granted to patients exposed to SM gas by 
the Veteran’s Affair of Iran (Janbazan Foundation). In 
the present study, the percentage of disability was only 
related to oral candidiasis but not other symptoms such 
as petechial lesions, pharyngeal erythema and herpes. 
Patients with higher percentages of disability had a grea-
ter risk of candidiasis infection, most probably because 
of their depressed cell-mediated immunity as reported 
previously (19-22). This immune suppression is the con-
sequence of both SM’s direct effects and the impact of 
immunosuppressive medications used by patients (21). 
With respect to the direct effects of SM, several immu-
nological imbalances have been reported in subjects su-
ffering from long-term complications of SM, including 
increased titres of C3, C4, IgG and IgM, and depressed 
cell-mediated immunity characterized by reduced num-
ber of natural killer cells (19-22).
Taken together, SM exposure was associated with in-
creased prevalence of oral candidiasis. However, this 
complication along with others due to the side effects 
of prescribed medications (pharyngeal erythema/hyper-
plasia and hairy tongue) were not found to cause long-
term dental decays, dental loss, or increased intra/extra 
oral lesions. The observed association between the use 
of salmeterol and pharyngeal erythema/hyperplasia may 
necessitate drug switching to other bronchodilators in 
SM-exposed subjects, or reducing salmeterol’s dose. 
Finally, in patients with higher percentages of disabili-
ty, care should be taken to prevent and treat oral can-
didiasis with antifungal drugs such as nystatin. Owing 
to the multi-organ damage and long-term complications 
of SM, continuous follow-up of exposed subjects is ne-
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cessary. Adherence to oral health principles and routine 
examinations by dentist is vital to prevent the develop-
ment of oral lesions and dental caries.
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